Graham Williams became Professor of Endocrinology at Imperial College London in 2005. He obtained a BSc in Anatomy and MBBS from St. Thomas’s Hospital, University of London and a PhD from the University of Birmingham. He trained as a Howard Hughes Medical Institute Fellow at Harvard Medical School, Boston, USA and as a Medical Research Council Training Fellow and Clinician Scientist Fellow at the University of Birmingham. He was appointed as Senior Lecturer at the Royal Postgraduate Medical School, London (1995) and received an MRC Career Establishment Award. He was promoted to Reader (2000) and subsequently Professor (2005).
Professor Williams is Head of the Molecular Endocrinology Laboratory in the Department of Medicine at Hammersmith Campus. His research focuses on the (i) genetic origins of bone and cartilage disease and (ii) molecular mechanisms of thyroid hormone action during skeletal development and in adult bone maintenance and tissue repair. This research is internationally recognised and the laboratory is generously funded by a Wellcome Trust Strategic Award, MRC Research Grant, European Commission Horizon 2020 Award and Wellcome Trust Investigator Award. Professor Williams receives regular invitations to speak at international scientific meetings all over the world and the laboratory collaborates widely throughout the UK, Europe, USA and Asia. Clinical Training Fellows, PhD students and post-doctoral scientists in the Molecular Endocrinology Group have received 33 prizes for research excellence.
Professor Williams was awarded the Society for Endocrinology Medal (2011), European Thyroid Association Merck Serono Prize (2012), Danish Thyroid Association Distinguished Annual Lectureship (2014), American Thyroid Association Sidney H. Ingbar Distinguished Lectureship Award (2014) and British Thyroid Association Pitt-Rivers Medal (2016). He received a Wellcome Trust Investigator Award (2016-2021).
Professor Williams is the current President of the Society for Endocrinology (2016-2019), having previously served as Treasurer and a Member of Council (2010-2015). He was President of the British Thyroid Association (2011-2014), and sat as a member of the British Thyroid Association Executive (2003-2009 & 2011-2015) and the European Thyroid Association Executive Committee (2008-2011).
Professor Williams has served on numerous Editorial Boards, Grant Review Panels and Scientific Programme Organising Committees over the years and is Director of Research within the Department of Medicine at Imperial College.
Freudenthal B, Williams GR, TSH suppression in the long-term follow-up of differentiated thyroid cancer, Clinical Oncology, ISSN:0936-6555
et al., Thyroid hormone receptor beta in the ventromedial hypothalamus is essential for the physiological regulation of food intake and body weight, Cell Reports, ISSN:2211-1247
et al., 2017, Thyroid function tests in the reference range and fracture: individual participant analysis of prospective cohorts., J Clin Endocrinol Metab
et al., 2017, Inhibiting the osteocyte specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma., Blood
Bassett JHD, Williams GR, 2016, Role of Thyroid Hormones in Skeletal Development and Bone Maintenance, Endocrine Reviews, Vol:37, ISSN:0163-769X, Pages:135-187